Lord Abbett & CO. LLC decreased its holdings in Docusign Inc. (NASDAQ:DOCU - Free Report) by 87.0% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund owned 67,305 shares of the company's stock after selling 450,750 shares during the quarter. Lord Abbett & CO. LLC's holdings in Docusign were worth $5,479,000 as of its most recent SEC filing.
Other institutional investors also recently modified their holdings of the company. New Age Alpha Advisors LLC grew its holdings in shares of Docusign by 738.2% in the 1st quarter. New Age Alpha Advisors LLC now owns 41,187 shares of the company's stock worth $3,353,000 after acquiring an additional 36,273 shares during the last quarter. Pinpoint Asset Management Ltd boosted its position in shares of Docusign by 54.3% in the 1st quarter. Pinpoint Asset Management Ltd now owns 56,985 shares of the company's stock valued at $4,639,000 after purchasing an additional 20,043 shares during the period. Concurrent Investment Advisors LLC acquired a new position in shares of Docusign in the 1st quarter valued at $618,000. Gilman Hill Asset Management LLC increased its stake in Docusign by 4.9% in the 1st quarter. Gilman Hill Asset Management LLC now owns 84,326 shares of the company's stock worth $6,864,000 after purchasing an additional 3,904 shares in the last quarter. Finally, Blair William & Co. IL raised its holdings in Docusign by 1.7% during the 1st quarter. Blair William & Co. IL now owns 387,542 shares of the company's stock worth $31,546,000 after buying an additional 6,460 shares during the period. Institutional investors own 77.64% of the company's stock.
Wall Street Analyst Weigh In
Several brokerages have commented on DOCU. UBS Group decreased their target price on shares of Docusign from $85.00 to $80.00 and set a "neutral" rating for the company in a report on Friday, June 6th. Robert W. Baird reduced their price target on shares of Docusign from $93.00 to $85.00 and set a "neutral" rating for the company in a research report on Friday, June 6th. Wells Fargo & Company upgraded shares of Docusign from an "underweight" rating to an "equal weight" rating and lifted their price objective for the stock from $67.00 to $80.00 in a research report on Friday, June 13th. Morgan Stanley cut their target price on shares of Docusign from $92.00 to $86.00 and set an "equal weight" rating on the stock in a research note on Friday, June 6th. Finally, Bank of America reduced their target price on Docusign from $88.00 to $85.00 and set a "neutral" rating for the company in a report on Friday, June 6th. Four investment analysts have rated the stock with a Buy rating and twelve have issued a Hold rating to the company. According to MarketBeat, the company currently has a consensus rating of "Hold" and a consensus target price of $89.77.
View Our Latest Research Report on Docusign
Docusign Trading Down 0.6%
DOCU stock traded down $0.4060 during midday trading on Thursday, reaching $70.6840. The company had a trading volume of 820,719 shares, compared to its average volume of 2,578,983. The company has a 50 day moving average of $75.56 and a two-hundred day moving average of $80.72. The company has a market capitalization of $14.28 billion, a P/E ratio of 13.37, a PEG ratio of 26.45 and a beta of 1.01. Docusign Inc. has a 1 year low of $54.31 and a 1 year high of $107.86.
Docusign (NASDAQ:DOCU - Get Free Report) last posted its quarterly earnings results on Thursday, June 5th. The company reported $0.90 earnings per share for the quarter, topping analysts' consensus estimates of $0.81 by $0.09. Docusign had a net margin of 36.50% and a return on equity of 14.27%. The business had revenue of $763.65 million for the quarter, compared to the consensus estimate of $748.79 million. During the same period in the prior year, the business posted $0.82 earnings per share. Docusign's revenue for the quarter was up 7.6% compared to the same quarter last year. Docusign has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. On average, sell-side analysts anticipate that Docusign Inc. will post 1.17 earnings per share for the current year.
Docusign declared that its board has authorized a share repurchase plan on Thursday, June 5th that allows the company to buyback $1.00 billion in outstanding shares. This buyback authorization allows the company to reacquire up to 6.6% of its stock through open market purchases. Stock buyback plans are often a sign that the company's management believes its shares are undervalued.
Insider Transactions at Docusign
In related news, CEO Allan C. Thygesen sold 40,000 shares of the stock in a transaction that occurred on Tuesday, July 1st. The stock was sold at an average price of $77.51, for a total value of $3,100,400.00. Following the transaction, the chief executive officer owned 143,983 shares in the company, valued at approximately $11,160,122.33. This represents a 21.74% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Teresa Briggs sold 534 shares of the firm's stock in a transaction that occurred on Monday, June 16th. The shares were sold at an average price of $74.37, for a total transaction of $39,713.58. Following the transaction, the director directly owned 8,805 shares in the company, valued at approximately $654,827.85. The trade was a 5.72% decrease in their position. The disclosure for this sale can be found here. Insiders sold 78,552 shares of company stock valued at $5,983,631 over the last 90 days. Company insiders own 1.01% of the company's stock.
About Docusign
(
Free Report)
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Featured Articles
Before you consider Docusign, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Docusign wasn't on the list.
While Docusign currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access